The interventional cardiology devices market was valued at US$ 16.89 billion in 2024 and is projected to reach US$ 30.23 billion by 2033, registering a CAGR of 7.55% during the forecast period ...

In the device segment of the interventional neuroradiology market, the flow diversion stents category had a significant revenue share in 2024, driven by their versatile applications, clinical ...

Johnson & Johnson MedTech issued a recall for its Biosense Webster Varipulse Bi-Directional Ablation Catheter following reports of strokes and transient ischemic attacks in patients undergoing ...